310 related articles for article (PubMed ID: 33458428)
1. Clinical implementation of magnetic resonance imaging guided adaptive radiotherapy for localized prostate cancer.
Tetar SU; Bruynzeel AME; Lagerwaard FJ; Slotman BJ; Bohoudi O; Palacios MA
Phys Imaging Radiat Oncol; 2019 Jan; 9():69-76. PubMed ID: 33458428
[TBL] [Abstract][Full Text] [Related]
2. Feasibility of Adaptive MR-guided Stereotactic Body Radiotherapy (SBRT) of Lung Tumors.
Padgett KR; Simpson GN; Llorente R; Samuels MA; Dogan N
Cureus; 2018 Apr; 10(4):e2423. PubMed ID: 29872603
[TBL] [Abstract][Full Text] [Related]
3. Time-Driven Activity-Based Costing of CT-Guided vs MR-Guided Prostate SBRT.
Parikh NR; Clark MA; Patel P; Kafka-Peterson K; Zaide L; Ma TM; Steinberg ML; Cao M; Raldow AC; Lamb J; Kishan AU
Appl Radiat Oncol; 2021 Sep; 10(3):33-40. PubMed ID: 34671700
[TBL] [Abstract][Full Text] [Related]
4. Dosimetric benefit of online treatment plan adaptation in stereotactic ultrahypofractionated MR-guided radiotherapy for localized prostate cancer.
Fink CA; Buchele C; Baumann L; Liermann J; Hoegen P; Ristau J; Regnery S; Sandrini E; König L; Rippke C; Bonekamp D; Schlemmer HP; Debus J; Koerber SA; Klüter S; Hörner-Rieber J
Front Oncol; 2024; 14():1308406. PubMed ID: 38425342
[TBL] [Abstract][Full Text] [Related]
5. Combined Inter- and Intrafractional Plan Adaptation Using Fraction Partitioning in Magnetic Resonance-guided Radiotherapy Delivery.
Lagerwaard F; Bohoudi O; Tetar S; Admiraal MA; Rosario TS; Bruynzeel A
Cureus; 2018 Apr; 10(4):e2434. PubMed ID: 29876156
[TBL] [Abstract][Full Text] [Related]
6. Patterns of utilization and clinical adoption of 0.35 Tesla MR-guided radiation therapy in the United States - Understanding the transition to adaptive, ultra-hypofractionated treatments.
Chuong MD; Clark MA; Henke LE; Kishan AU; Portelance L; Parikh PJ; Bassetti MF; Nagar H; Rosenberg SA; Mehta MP; Refaat T; Rineer JM; Smith A; Seung S; Zaki BI; Fuss M; Mak RH
Clin Transl Radiat Oncol; 2023 Jan; 38():161-168. PubMed ID: 36466748
[TBL] [Abstract][Full Text] [Related]
7. Identification of patients with locally advanced pancreatic cancer benefitting from plan adaptation in MR-guided radiation therapy.
Bohoudi O; Bruynzeel AME; Meijerink MR; Senan S; Slotman BJ; Palacios MA; Lagerwaard FJ
Radiother Oncol; 2019 Mar; 132():16-22. PubMed ID: 30825964
[TBL] [Abstract][Full Text] [Related]
8. Non-Adaptive MR-Guided Radiotherapy for Prostate SBRT: Less Time, Equal Results.
Sandoval ML; Youssef I; Latifi K; Grass GD; Torres-Roca J; Rosenberg S; Yamoah K; Johnstone PA
J Clin Med; 2021 Jul; 10(15):. PubMed ID: 34362179
[TBL] [Abstract][Full Text] [Related]
9. A Prospective Single-Arm Phase 2 Study of Stereotactic Magnetic Resonance Guided Adaptive Radiation Therapy for Prostate Cancer: Early Toxicity Results.
Bruynzeel AME; Tetar SU; Oei SS; Senan S; Haasbeek CJA; Spoelstra FOB; Piet AHM; Meijnen P; Bakker van der Jagt MAB; Fraikin T; Slotman BJ; van Moorselaar RJA; Lagerwaard FJ
Int J Radiat Oncol Biol Phys; 2019 Dec; 105(5):1086-1094. PubMed ID: 31419510
[TBL] [Abstract][Full Text] [Related]
10. First 500 Fractions Delivered with a Magnetic Resonance-guided Radiotherapy System: Initial Experience.
Sahin B; Zoto Mustafayev T; Gungor G; Aydin G; Yapici B; Atalar B; Ozyar E
Cureus; 2019 Dec; 11(12):e6457. PubMed ID: 32025388
[TBL] [Abstract][Full Text] [Related]
11. Medical physics challenges in clinical MR-guided radiotherapy.
Kurz C; Buizza G; Landry G; Kamp F; Rabe M; Paganelli C; Baroni G; Reiner M; Keall PJ; van den Berg CAT; Riboldi M
Radiat Oncol; 2020 May; 15(1):93. PubMed ID: 32370788
[TBL] [Abstract][Full Text] [Related]
12. The Role of Daily Adaptive Stereotactic MR-Guided Radiotherapy for Renal Cell Cancer.
Tetar SU; Bohoudi O; Senan S; Palacios MA; Oei SS; Wel AMV; Slotman BJ; Moorselaar RJAV; Lagerwaard FJ; Bruynzeel AME
Cancers (Basel); 2020 Sep; 12(10):. PubMed ID: 32992844
[TBL] [Abstract][Full Text] [Related]
13. First experience of autonomous, un-supervised treatment planning integrated in adaptive MR-guided radiotherapy and delivered to a patient with prostate cancer.
Künzel LA; Nachbar M; Hagmüller M; Gani C; Boeke S; Zips D; Thorwarth D
Radiother Oncol; 2021 Jun; 159():197-201. PubMed ID: 33812912
[TBL] [Abstract][Full Text] [Related]
14. Operating procedures, risk management and challenges during implementation of adaptive and non-adaptive MR-guided radiotherapy: 1-year single-center experience.
Garcia Schüler HI; Pavic M; Mayinger M; Weitkamp N; Chamberlain M; Reiner C; Linsenmeier C; Balermpas P; Krayenbühl J; Guckenberger M; Baumgartl M; Wilke L; Tanadini-Lang S; Andratschke N
Radiat Oncol; 2021 Nov; 16(1):217. PubMed ID: 34775998
[TBL] [Abstract][Full Text] [Related]
15. Daily dosimetric variation between image-guided volumetric modulated arc radiotherapy and MR-guided daily adaptive radiotherapy for prostate cancer stereotactic body radiotherapy.
Nicosia L; Sicignano G; Rigo M; Figlia V; Cuccia F; De Simone A; Giaj-Levra N; Mazzola R; Naccarato S; Ricchetti F; Vitale C; Ruggieri R; Alongi F
Acta Oncol; 2021 Feb; 60(2):215-221. PubMed ID: 32945701
[TBL] [Abstract][Full Text] [Related]
16. Optimization of treatment planning workflow and tumor coverage during daily adaptive magnetic resonance image guided radiation therapy (MR-IGRT) of pancreatic cancer.
Olberg S; Green O; Cai B; Yang D; Rodriguez V; Zhang H; Kim JS; Parikh PJ; Mutic S; Park JC
Radiat Oncol; 2018 Mar; 13(1):51. PubMed ID: 29573744
[TBL] [Abstract][Full Text] [Related]
17. Magnetic Resonance-guided Stereotactic Radiotherapy for Localized Prostate Cancer: Final Results on Patient-reported Outcomes of a Prospective Phase 2 Study.
Tetar SU; Bruynzeel AME; Oei SS; Senan S; Fraikin T; Slotman BJ; Moorselaar RJAV; Lagerwaard FJ
Eur Urol Oncol; 2021 Aug; 4(4):628-634. PubMed ID: 32536573
[TBL] [Abstract][Full Text] [Related]
18. Online adaptive MR-guided radiotherapy for rectal cancer; feasibility of the workflow on a 1.5T MR-linac: clinical implementation and initial experience.
Intven MPW; de Mol van Otterloo SR; Mook S; Doornaert PAH; de Groot-van Breugel EN; Sikkes GG; Willemsen-Bosman ME; van Zijp HM; Tijssen RHN
Radiother Oncol; 2021 Jan; 154():172-178. PubMed ID: 32976875
[TBL] [Abstract][Full Text] [Related]
19. Online Magnetic Resonance Image Guided Adaptive Radiation Therapy: First Clinical Applications.
Acharya S; Fischer-Valuck BW; Kashani R; Parikh P; Yang D; Zhao T; Green O; Wooten O; Li HH; Hu Y; Rodriguez V; Olsen L; Robinson C; Michalski J; Mutic S; Olsen J
Int J Radiat Oncol Biol Phys; 2016 Feb; 94(2):394-403. PubMed ID: 26678659
[TBL] [Abstract][Full Text] [Related]
20. Intrafractional stability of MR-guided online adaptive SBRT for prostate cancer.
Schaule J; Chamberlain M; Wilke L; Baumgartl M; Krayenbühl J; Zamburlini M; Mayinger M; Andratschke N; Tanadini-Lang S; Guckenberger M
Radiat Oncol; 2021 Sep; 16(1):189. PubMed ID: 34565439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]